(Q40025013)

16 September 2017

Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression (English)

1 reference

16 September 2017

Isis C Sroka

1

1 reference

16 September 2017

Kathy McDaniel

series ordinal

2

1 reference

16 September 2017

Raymond B Nagle

series ordinal

3

1 reference

16 September 2017

G Tim Bowden

series ordinal

4

1 reference

16 September 2017

1 April 2008

1 reference

16 September 2017

1 reference

16 September 2017

68

1 reference

16 September 2017

5

1 reference

16 September 2017

463-476

1 reference

MT1-MMP and MMP-7 in invasion and metastasis of human cancers

16 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Mislocalization and unconventional functions of cellular MMPs in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Membrane type-matrix metalloproteinases and tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

MT1-MMP: a potent modifier of pericellular microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Role of insulin-like growth factor 1 receptor signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

The IGF-1 receptor and its contributions to metastatic tumor growth-novel approaches to the inhibition of IGF-1R function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Silencing of the type 1 insulin-like growth factor receptor increases the sensitivity to apoptosis and inhibits invasion in human lung adenocarcinoma A549 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Suppression of type 1 Insulin-like growth factor receptor expression by small interfering RNA inhibits A549 human lung cancer cell invasion in vitro and metastasis in xenograft nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Identification of a novel structural variant of the alpha 6 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Interaction of IGF signaling and the androgen receptor in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20718

21 January 2018

Identifiers

DOI

10.1002/PROS.20718

1 reference

16 September 2017

1 reference